Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  CVS Health Corporation    CVS

CVS HEALTH CORPORATION

(CVS)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsOfficial PublicationsSector newsAnalyst Recommendations

CVS Health : raises 2019 profit forecast after beating profit estimates

share with twitter share with LinkedIn share with facebook
share via e-mail
0
08/07/2019 | 02:57pm EDT
A logo of CVS Health is displayed on a monitor above the floor of the New York Stock Exchange shortly after the opening bell in New York

(Reuters) - CVS Health Corp raised its full-year profit forecast and reported higher-than-expected second-quarter results on Wednesday, as increased U.S. prescription drug prices fueled rebates to its pharmacy benefits business.

CVS shares were up 6.6% at $57.65, while the broader market was down about 0.5%.

The company, which last year bought health insurer Aetna for $69 billion, raised its full-year adjusted earnings forecast to $6.89 to $7.00 per share, up from $6.75 to $6.90.

Pharmacy benefit manager (PBM) revenue rose 4.2% to $34.84 billion in the quarter, exceeding Wall Street estimates of $34.2 billion compiled by Evercore ISI. But the company said high dispensing rates of cheap generic drugs limited growth.

CVS also said it expects increased competition for its PBM business in 2020.

Revenue of $21.45 billion from its retail drugstore chains, which compete with Walgreens Boots Alliance Inc, was up 3.7% and also edged past analysts' estimates. But CVS said it is seeing less profit per prescription filled.

Walgreens on Tuesday said it planned to close about 200 U.S. stores, months after saying it would do the same in Britain.

CVS is working to bring more health services into its pharmacies and hopes to drive Aetna clients to take advantage of cheaper care for chronic conditions at its in-store clinics - one of the primary advantages of the acquisition.

The company said it was already seeing increased customer traffic and sales at walk-in clinics and retail stores where it has opened "HealthHub" pilot pharmacies that provide chronic care management for diabetes and other common health problems.

CVS said it plans to expand the pilot project to 50 stores in four metropolitan areas by the end of 2019 and to 1,500 stores by the end of 2021.

Chief Executive Larry Merlo said in a phone interview that the company was repurposing capital originally earmarked for opening new stores or remodeling existing ones for the HealthHub project.

"It's not new capital for us. It's capital that we would have spent on our real estate program, so there's no incremental spend," he said.

Evercore ISI analyst Ross Muken said the company's approach to the HealthHubs makes good strategic sense.

"In general the message was 'we are making progress despite the headwinds swirling around,'" Muken said

Those headwinds include intensifying political pressure to lower the cost of U.S. healthcare amid legislative proposals that take aim at insurers and PBMs.

The Aetna business reported revenue of $17.4 billion.

Excluding items, CVS earned $1.89 per share, topping analysts' estimates by 20 cents, according to IBES data from Refinitiv.

(Reporting by Manas Mishra and Tamara Mathias in Bengaluru; Michael Erman in New York; Editing by Maju Samuel and Bill Berkrot)

By Manas Mishra and Tamara Mathias

Stocks mentioned in the article
ChangeLast1st jan.
CVS HEALTH CORPORATION -0.35% 63.26 Delayed Quote.-3.45%
WALGREENS BOOTS ALLIANCE -0.78% 54.41 Delayed Quote.-20.37%
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on CVS HEALTH CORPORATION
09/16Opioid plaintiffs fight bid to disqualify U.S. judge before trial
RE
09/16IMPORTANT INVESTOR REMINDER : The Schall Law Firm Announces the Filing of a Clas..
BU
09/13The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against CV..
BU
09/13Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against CV..
BU
09/12CVS HEALTH : Google Photos and CVS Pharmacy Team Up to Offer Same-Day Printing a..
PR
09/11Surescripts in Dispute With ReMy Health -CNBC
DJ
09/09Walgreens Boots Alliance on Pace for Largest Percent Increase in Over a Year ..
DJ
09/09CVS HEALTH : American College of Rheumatology - Rheumatology Leaders Concerned C..
AQ
09/09AETNA : Voices of Health Competition Kicks Off Today
PR
09/06ALPHABET, MATCH GROUP, CVS : Stocks That Defined The Week
DJ
More news
Financials (USD)
Sales 2019 253 B
EBIT 2019 15 012 M
Net income 2019 6 583 M
Debt 2019 63 327 M
Yield 2019 3,15%
P/E ratio 2019 12,5x
P/E ratio 2020 11,3x
EV / Sales2019 0,58x
EV / Sales2020 0,54x
Capitalization 82 269 M
Chart CVS HEALTH CORPORATION
Duration : Period :
CVS Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends CVS HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 28
Average target price 71,69  $
Last Close Price 63,26  $
Spread / Highest target 45,4%
Spread / Average Target 13,3%
Spread / Lowest Target -8,31%
EPS Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
Eva C. Boratto Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President